BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Dietary Pea Fiber Supplementation Improves Glycemia and Induces Changes in the Composition of Gut Microbiota, Serum Short Chain Fatty Acid Profile and Expression of Mucins in Glucose Intolerant Rats. ✅
Nutrients (Nutrients ) Vol: 9 Issue 11 Pages: Pub: 2017 Nov 12 Epub: 2017 Nov 12 Authors Hashemi Z , Fouhse J , Im HS , Chan CB , Willing BP , |
|
|
Food for thought about manipulating gut bacteria. ✅
Go to Publication ✅
Nature (Nature ) Vol: 577 Issue 7788 Pages: 32-34 Pub: 2020 Jan Epub: Authors Delzenne NM , Bindels LB , |
|
|
sRAGE-binding and antimicrobial bioactivities of soy and pea protein after heating and in vitro infant digestion. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 183 Issue Pages: 114224 Pub: 2024 May Epub: 2024 Mar 12 Authors Tang J , Teodorowicz M , Boeren S , Wichers HJ , Hettinga KA , |
|
|
Dietary Amylose/Amylopectin Ratio Modulates Cecal Microbiota and Metabolites in Weaned Goats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 774766 Pub: 2021 Epub: 2021 Nov 23 Authors Gebeyew K , Chen K , Wassie T , Azad MAK , He J , Jiang W , Song W , He Z , Tan Z , |
|
|
Dietary Amylose/Amylopectin Ratio Modulates Cecal Microbiota and Metabolites in Weaned Goats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 774766 Pub: 2021 Epub: 2021 Nov 23 Authors Gebeyew K , Chen K , Wassie T , Azad MAK , He J , Jiang W , Song W , He Z , Tan Z , |
|
|
Microbiome-Metabolomics Analysis Investigating the Impacts of Dietary Starch Types on the Composition and Metabolism of Colonic Microbiota in Finishing Pigs. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1143 Pub: 2019 Epub: 2019 May 29 Authors Yu M , Li Z , Chen W , Rong T , Wang G , Ma X , |
|
|
Microbiome-Metabolomics Analysis Investigating the Impacts of Dietary Starch Types on the Composition and Metabolism of Colonic Microbiota in Finishing Pigs. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1143 Pub: 2019 Epub: 2019 May 29 Authors Yu M , Li Z , Chen W , Rong T , Wang G , Ma X , |
|
|
Microbiome-Metabolomics Analysis Investigating the Impacts of Dietary Starch Types on the Composition and Metabolism of Colonic Microbiota in Finishing Pigs. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1143 Pub: 2019 Epub: 2019 May 29 Authors Yu M , Li Z , Chen W , Rong T , Wang G , Ma X , |
|
|
In vitro utilization of amylopectin and high-amylose maize (Amylomaize) starch granules by human colonic bacteria. ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 65 Issue 11 Pages: 4848-54 Pub: 1999 Nov Epub: Authors Wang X , Conway PL , Brown IL , Evans AJ , |
|
|
Fabrication and characterization of novel electrospun nanofibers based on grass pea (Lathyrus sativus L.) protein isolate loaded with sumac (Rhus coriaria L.) extract. ✅
Go to Publication ✅
Current research in food science (Curr Res Food Sci ) Vol: 9 Issue Pages: 100891 Pub: 2024 Epub: 2024 Nov 9 Authors Rezaei M , Sedaghat N , Hedayati S , Golmakani MT , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
